259 related articles for article (PubMed ID: 16300453)
1. Update on the efficacy of angiotensin receptor blockers in treatment of hypertension.
Am J Manag Care; 2005 Nov; 11(13 Suppl):S386-91. PubMed ID: 16300453
[TBL] [Abstract][Full Text] [Related]
2. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
5. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor blockers and congestive heart failure.
Auer JW; Berent R; Eber B
Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
[No Abstract] [Full Text] [Related]
7. Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?
Weber MA
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):62-73. PubMed ID: 12806587
[TBL] [Abstract][Full Text] [Related]
8. Are angiotensin II receptor antagonists indicated in chronic heart failure?
Komajda M
Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
[TBL] [Abstract][Full Text] [Related]
9. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-II receptor antagonists: a new class of antihypertensive agents.
Weir MR
Am Fam Physician; 1996 Feb; 53(2):589-94. PubMed ID: 8629540
[TBL] [Abstract][Full Text] [Related]
11. [The significance of generic valsartan in the treatment of patients].
Vértes A
Lege Artis Med; 2011 Feb; 21(2):117-21. PubMed ID: 21710709
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Gaddam KK; Oparil S
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):484-90. PubMed ID: 18695389
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
14. [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].
Stern N; Grossman E; ; ; ;
Harefuah; 2003 Apr; 142(4):309-11, 315. PubMed ID: 12754885
[TBL] [Abstract][Full Text] [Related]
15. [Use of angiotensin-II-antagonists in hypertension].
Birkenhäger WH; de Leeuw PW
Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1397-402. PubMed ID: 10923148
[TBL] [Abstract][Full Text] [Related]
16. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists role in arterial hypertension.
Hernández-Hernández R; Sosa-Canache B; Velasco M; Armas-Hernández MJ; Armas-Padilla MC; Cammarata R
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S93-9. PubMed ID: 11986904
[TBL] [Abstract][Full Text] [Related]
18. Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
Volpe M
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):1061-72. PubMed ID: 23030295
[TBL] [Abstract][Full Text] [Related]
19. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
Abassi Z; Winaver J; Feuerstein GZ
Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
[TBL] [Abstract][Full Text] [Related]
20. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
Karalliedde J; Viberti G
J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
